{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:21:59Z","timestamp":1771615319762,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006452","name":"UOM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UGC-BSR"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.peptides.2019.170180","type":"journal-article","created":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T01:22:42Z","timestamp":1573348962000},"page":"170180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Combinatorial inhibition of Angiotensin converting enzyme, Neutral endopeptidase and Aminopeptidase N by N-methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension"],"prefix":"10.1016","volume":"123","author":[{"given":"Mysuru Natarajan","family":"Savitha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanve Nagaraj","family":"Suvilesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalahalli Mariswamy","family":"Siddesha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Milan Gowda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devadasan","family":"Velmurugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muddegowda","family":"Umashankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bannikuppe Sannanaik","family":"Vishwanath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2017","key":"10.1016\/j.peptides.2019.170180_bib0005","article-title":"The worldwide burden of hypertension","author":"Harlan","year":"2017","journal-title":"NEJM J. Watch"},{"key":"10.1016\/j.peptides.2019.170180_bib0010","first-page":"866","article-title":"End organ damage in hypertension","volume":"107","author":"Schmieder","year":"2010","journal-title":"Arztebl. Int."},{"key":"10.1016\/j.peptides.2019.170180_bib0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1586\/14779072.5.3.531","article-title":"Vasoactive peptides in cardiovascular (patho)physiology","volume":"5","author":"Callera","year":"2007","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.peptides.2019.170180_bib0020","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"Suppl 5","key":"10.1016\/j.peptides.2019.170180_bib0025","first-page":"S19","article-title":"Role of angiotensin II in blood pressure485 regulation and in the pathophysiology of cardiovascular disorders","volume":"9","author":"Fyhrquist","year":"1995","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.peptides.2019.170180_bib0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/eurheartj\/ehs262","article-title":"Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics","volume":"34","author":"Mangiafico","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.peptides.2019.170180_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/CS20150469","article-title":"The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment","volume":"130","author":"Volpe","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.peptides.2019.170180_bib0040","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/hy0202.103821","article-title":"Regulation of intrarenal angiotensin II in hypertension","volume":"39","author":"Navar","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2019.170180_bib0045","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/hc4001.097191","article-title":"Vasopeptidase inhibitors:a new therapeutic concept in cardiovascular disease?","volume":"104","author":"Corti","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2019.170180_bib0050","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/HJH.0b013e3282f5ed58","article-title":"Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat","volume":"26","author":"Yang","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.peptides.2019.170180_bib0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.HYP.0000254833.85106.4d","article-title":"Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats","volume":"49","author":"Padia","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2019.170180_bib0060","first-page":"83","article-title":"Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure","volume":"10","author":"Xu","year":"2004","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.peptides.2019.170180_bib0065","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(01)06584-9","article-title":"Vasopeptidase inhibitors","volume":"358","author":"Weber","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2019.170180_bib0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.HYP.17.4.589","article-title":"History of the design of captopril and related inhibitors of angiotensin converting enzyme","volume":"17","author":"Cushman","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2019.170180_bib0075","article-title":"Active-site directed peptide L-Phe-D-His-L-Leu inhibits angiotensin converting enzyme activity and dexamethasone-induced hypertension in rats","author":"Savitha","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2019.170180_bib0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bip.22073","article-title":"Protease-resistant peptide designempowering nature\u2019s fragile warriors against HIV","volume":"98","author":"Weinstock","year":"2012","journal-title":"Biopolymers"},{"key":"10.1016\/j.peptides.2019.170180_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23110","article-title":"N-methylation in amino acids and peptides: scope and limitations","volume":"109","author":"Sharma","year":"2018","journal-title":"Biopolymers"},{"key":"10.1016\/j.peptides.2019.170180_bib0090","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1021\/jo901643f","article-title":"An efficient preparation of N-methyl-alpha-amino acids from N-nosyl-alpha-amino acid phenacyl esters","volume":"75","author":"Leggio","year":"2010","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.peptides.2019.170180_bib0095","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1021\/jo070438i","article-title":"N-methyl-N-nosyl-beta(3)-amino acids","volume":"72","author":"Belsito","year":"2007","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.peptides.2019.170180_bib0100","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.bmc.2017.08.031","article-title":"Improving oral bioavailability of cyclic peptides by N-methylation","volume":"26","author":"R\u00e4der","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.peptides.2019.170180_bib0105","doi-asserted-by":"crossref","DOI":"10.1021\/ar8000603","article-title":"N-methylation of peptides: a new perspective in medicinal chemistry","author":"Chatterjee","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.peptides.2019.170180_bib0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2019.170180_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2410129","article-title":"A high-molecular mass neutral endopeptidase-24.5 from human lung","volume":"241","author":"Zolfaghari","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.peptides.2019.170180_bib0120","doi-asserted-by":"crossref","first-page":"12458","DOI":"10.1074\/jbc.M511277200","article-title":"Aminopeptidase N (CD13) regulates tumor necrosis factor-alpha induced apoptosis in human neutrophils","volume":"281","author":"Cowburn","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.170180_bib0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1006991009036","article-title":"Dexamethasone induced alterations in the levels of proteases involved in blood pressure homeostasis and blood coagulation in rats","volume":"197","author":"Rajashree","year":"1999","journal-title":"Mol. Cell.Biochem."},{"key":"10.1016\/j.peptides.2019.170180_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090822","article-title":"Gender-specific potential inhibitory role of Ca2+\/calmodulin dependent protein kinase phosphatase (CaMKP) in pressure-overloaded mouse heart","volume":"9","author":"Pr\u00e9vilon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170180_bib0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1369\/0022155414545787","article-title":"Picrosirius red staining: a useful tool to appraise collagen networks in normal and pathological tissues","volume":"62","author":"Lattouf","year":"2014","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.peptides.2019.170180_bib0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.111.00791","article-title":"Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men","volume":"62","author":"Asferg","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2019.170180_bib0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc14-1958","article-title":"Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes","volume":"38","author":"Lovshin","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2019.170180_bib0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.peptides.2019.170180_bib0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10989-016-9534-8","article-title":"Peptides as \u2018drugs\u2019: the journey so far","volume":"23","author":"Sachdeva","year":"2017","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.peptides.2019.170180_bib0160","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature01370","article-title":"Crystal structure of the human angiotensin-converting enzyme-lisinopril complex","volume":"421","author":"Natesh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2019.170180_bib0165","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/ar8000603","article-title":"N-methylation of peptides: a new perspective in medicinal chemistry","volume":"41","author":"Chatterjee","year":"2008","journal-title":"Acc. Chem. Res."},{"issue":"Suppl 1","key":"10.1016\/j.peptides.2019.170180_bib0170","first-page":"17","article-title":"Lisinopril in the treatment of hypertension","volume":"3","author":"Messerli","year":"1989","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.peptides.2019.170180_bib0175","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1177\/106002809202601012","article-title":"Fatal angioedema associated with lisinopril","volume":"26","author":"Ulmer","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.peptides.2019.170180_bib0180","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.HYP.0000168944.29525.da","article-title":"Dual ECE\/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats","volume":"45","author":"Emoto","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2019.170180_bib0185","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0895-7061(01)02157-4","article-title":"Effect of ACE\/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats","volume":"14","author":"Pu","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.peptides.2019.170180_bib0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pharmthera.2014.05.002","article-title":"Current role of neprilysin inhibitors in hypertension and heart failure","volume":"144","author":"von Lueder","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.peptides.2019.170180_bib0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-3565(24)38136-4","article-title":"Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels","volume":"289","author":"Duncan","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2019.170180_bib0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2019.170180_bib0205","first-page":"569","article-title":"Angiotensin II as a pro-inflammatory mediator","volume":"3","author":"Phillips","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.peptides.2019.170180_bib0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0300-9572(89)90031-2","article-title":"Angiotensin II and atrial natriuretic peptide in the brain: effects on volume and Na+ balance","volume":"18","author":"Unger","year":"1989","journal-title":"Resuscitation"},{"key":"10.1016\/j.peptides.2019.170180_bib0215","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:48:00Z","timestamp":1762264080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119301585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":43,"alternative-id":["S0196978119301585"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170180","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial inhibition of Angiotensin converting enzyme, Neutral endopeptidase and Aminopeptidase N by N-methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170180"}}